293 related articles for article (PubMed ID: 17250864)
1. In vitro and in vivo characterization of equine herpesvirus type 1 (EHV-1) mutants devoid of the viral chemokine-binding glycoprotein G (gG).
von Einem J; Smith PM; Van de Walle GR; O'Callaghan DJ; Osterrieder N
Virology; 2007 May; 362(1):151-62. PubMed ID: 17250864
[TBL] [Abstract][Full Text] [Related]
2. Equine herpesvirus 1 mutants devoid of glycoprotein B or M are apathogenic for mice but induce protection against challenge infection.
Neubauer A; Beer M; Brandmüller C; Kaaden OR; Osterrieder N
Virology; 1997 Dec; 239(1):36-45. PubMed ID: 9426444
[TBL] [Abstract][Full Text] [Related]
3. The role of secreted glycoprotein G of equine herpesvirus type 1 and type 4 (EHV-1 and EHV-4) in immune modulation and virulence.
Thormann N; Van de Walle GR; Azab W; Osterrieder N
Virus Res; 2012 Oct; 169(1):203-11. PubMed ID: 22902480
[TBL] [Abstract][Full Text] [Related]
4. An equine herpesvirus type 1 recombinant with a deletion in the gE and gI genes is avirulent in young horses.
Matsumura T; Kondo T; Sugita S; Damiani AM; O'Callaghan DJ; Imagawa H
Virology; 1998 Mar; 242(1):68-79. PubMed ID: 9501037
[TBL] [Abstract][Full Text] [Related]
5. The equine herpesvirus 1 IR6 protein influences virus growth at elevated temperature and is a major determinant of virulence.
Osterrieder N; Neubauer A; Brandmüller C; Kaaden OR; O'Callaghan DJ
Virology; 1996 Dec; 226(2):243-51. PubMed ID: 8955044
[TBL] [Abstract][Full Text] [Related]
6. [Mutations in the US2 and glycoprotein B genes of the equine herpesvirus 1 vaccine strain RacH have no effects on its attenuation].
Neubauer A; Meindl A; Osterrieder N
Berl Munch Tierarztl Wochenschr; 1999 Sep; 112(9):351-4. PubMed ID: 10507185
[TBL] [Abstract][Full Text] [Related]
7. The truncated form of glycoprotein gp2 of equine herpesvirus 1 (EHV-1) vaccine strain KyA is not functionally equivalent to full-length gp2 encoded by EHV-1 wild-type strain RacL11.
von Einem J; Wellington J; Whalley JM; Osterrieder K; O'Callaghan DJ; Osterrieder N
J Virol; 2004 Mar; 78(6):3003-13. PubMed ID: 14990719
[TBL] [Abstract][Full Text] [Related]
8. Argentine strain of equine herpesvirus 1 isolated from an aborted foetus shows low virulence in mouse respiratory and abortion models.
Galosi CM; Barbeito CG; Vila Roza MV; Cid de la Paz V; Ayala MA; Corva SG; Etcheverrigaray ME; Gimeno EJ
Vet Microbiol; 2004 Oct; 103(1-2):1-12. PubMed ID: 15381260
[TBL] [Abstract][Full Text] [Related]
9. Glycoprotein G deletion mutants of equine herpesvirus 1 (EHV1; equine abortion virus) and EHV4 (equine rhinopneumonitis virus).
Huang J; Hartley CA; Ficorilli NP; Crabb BS; Studdert MJ
Arch Virol; 2005 Dec; 150(12):2583-92. PubMed ID: 16052277
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the contributions of the equine herpesvirus 1 glycoprotein gB homolog to virus entry and direct cell-to-cell spread.
Neubauer A; Braun B; Brandmuller C; Kaaden OR; Osterrieder N
Virology; 1997 Jan; 227(2):281-94. PubMed ID: 9018127
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of virus-specific classes of antibodies following immunization of mice with attenuated equine herpesvirus 1 and viral glycoprotein D.
Zhang Y; Smith PM; Jennings SR; O'Callaghan DJ
Virology; 2000 Mar; 268(2):482-92. PubMed ID: 10704356
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic potential of equine alphaherpesviruses: the importance of the mononuclear cell compartment in disease outcome.
Osterrieder N; Van de Walle GR
Vet Microbiol; 2010 Jun; 143(1):21-8. PubMed ID: 20202764
[TBL] [Abstract][Full Text] [Related]
13. Expression of the full-length form of gp2 of equine herpesvirus 1 (EHV-1) completely restores respiratory virulence to the attenuated EHV-1 strain KyA in CBA mice.
Smith PM; Kahan SM; Rorex CB; von Einem J; Osterrieder N; O'Callaghan DJ
J Virol; 2005 Apr; 79(8):5105-15. PubMed ID: 15795295
[TBL] [Abstract][Full Text] [Related]
14. Equine herpesvirus type-1 modulates CCL2, CCL3, CCL5, CXCL9, and CXCL10 chemokine expression.
Wimer CL; Damiani A; Osterrieder N; Wagner B
Vet Immunol Immunopathol; 2011 Apr; 140(3-4):266-74. PubMed ID: 21349590
[TBL] [Abstract][Full Text] [Related]
15. An equine herpesvirus-1 gene 71 deletant is attenuated and elicits a protective immune response in mice.
Marshall KR; Sun Y; Brown SM; Field HJ
Virology; 1997 Apr; 231(1):20-7. PubMed ID: 9143298
[TBL] [Abstract][Full Text] [Related]
16. The ORF37 (UL24) is a neuropathogenicity determinant of equine herpesvirus 1 (EHV-1) in the mouse encephalitis model.
Kasem S; Yu MH; Yamada S; Kodaira A; Matsumura T; Tsujimura K; Madbouly H; Yamaguchi T; Ohya K; Fukushi H
Virology; 2010 May; 400(2):259-70. PubMed ID: 20199788
[TBL] [Abstract][Full Text] [Related]
17. Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse.
Weerasinghe CU; Learmonth GS; Gilkerson JR; Foote CE; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2006 May; 111(1-2):59-66. PubMed ID: 16473414
[TBL] [Abstract][Full Text] [Related]
18. Herpesvirus chemokine-binding glycoprotein G (gG) efficiently inhibits neutrophil chemotaxis in vitro and in vivo.
Van de Walle GR; May ML; Sukhumavasi W; von Einem J; Osterrieder N
J Immunol; 2007 Sep; 179(6):4161-9. PubMed ID: 17785855
[TBL] [Abstract][Full Text] [Related]
19. Contribution of gene products encoded within the unique short segment of equine herpesvirus 1 to virulence in a murine model.
Frampton AR; Smith PM; Zhang Y; Matsumura T; Osterrieder N; O'Callaghan DJ
Virus Res; 2002 Dec; 90(1-2):287-301. PubMed ID: 12457983
[TBL] [Abstract][Full Text] [Related]
20. EHV-1 glycoprotein D (EHV-1 gD) is required for virus entry and cell-cell fusion, and an EHV-1 gD deletion mutant induces a protective immune response in mice.
Csellner H; Walker C; Wellington JE; McLure LE; Love DN; Whalley JM
Arch Virol; 2000; 145(11):2371-85. PubMed ID: 11205124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
